Envoy Medical Inc

Envoy Medical Inc(COCH)の株式分析

$7.150

+0.050 (+0.70%)終値時点

Loading chart…
高値
7.240
始値
7.050
出来高加重平均価格
7.10
出来高
50.48K
時価総額
44.88M
安値
6.900
売買代金
358.20K
EV/EBITDA(TTM)
-1.23

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

www.envoymedical.com

AI分析 of Envoy Medical Inc (COCH)

買い

Envoy Medical Inc is a good buy right now due to its recent performance and positive outlook. The current price is $6.65, which is significantly below the analyst price targets of $2.00 and $2.50, indicating a potential upside. Additionally, the stock has shown a remarkable year-to-date change of +855.87% and a 20-day change of +921.51%, reflecting strong momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.70 for the upcoming earnings report, which could impact investor sentiment.

バリュエーション指標

Envoy Medical Inc(COCH)の現在の予想PERは0.00で、5年平均は-1.83です。

予想PER

割高
5年平均 P/E
-1.83
現在のP/E
0.00
割高
-0.18
割安
-3.47

予想EV/EBITDA

適正
5年平均 EV/EBITDA
-1.22
現在のEV/EBITDA
-1.23
割高
0.67
割安
-3.10

予想PSR

適正
5年平均 P/S
113.45
現在のP/S
201.61
割高
203.65
割安
23.26

Alphio AI による COCH の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%COCH

$1.15

シナリオ価格

基

基本

基本 · 50%COCH

$1.10

シナリオ価格

弱

弱気

弱気 · 25%COCH

$1.10

シナリオ価格

イベントタイムライン

2026-10-26 (ET)

10:00:00

Envoy Medical Inc Trading Halted

2026-10-23 (ET)

20:00:00

Envoy Medical Inc Trading Halted, News Pending

2026-06-02 (ET)

08:50:00

Envoy Medical Signs Media Deal with New to The Street

2025-12-18 (ET)

17:30:00

Envoy Medical Files to Sell Class A Common Stock

2024-11-14 (ET)

07:42:28

Envoy Medical reports Q3 EPS (37c) vs. 13c last year.

ニュース

COCH のよくある質問 — Alphio AI が回答

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Envoy Medical Inc is a good buy right now due to its recent performance and positive outlook. The current price is $6.65, which is significantly below the analyst price targets of $2.00 and $2.50, indicating a potential upside. Additionally, the stock has shown a remarkable year-to-date change of +855.87% and a 20-day change of +921.51%, reflecting strong momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.70 for the upcoming earnings report, which could impact investor sentiment.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める